ATE204604T1 - Strukturanaloge von fibroblasten- wachstumsfaktoren, die eine modifizierte heparin- bindungsstelle aufweisen - Google Patents

Strukturanaloge von fibroblasten- wachstumsfaktoren, die eine modifizierte heparin- bindungsstelle aufweisen

Info

Publication number
ATE204604T1
ATE204604T1 AT94114212T AT94114212T ATE204604T1 AT E204604 T1 ATE204604 T1 AT E204604T1 AT 94114212 T AT94114212 T AT 94114212T AT 94114212 T AT94114212 T AT 94114212T AT E204604 T1 ATE204604 T1 AT E204604T1
Authority
AT
Austria
Prior art keywords
heparin binding
binding site
growth factors
fibroblast growth
analogues
Prior art date
Application number
AT94114212T
Other languages
German (de)
English (en)
Inventor
Lu-Yuan Li
Andrew Peter Seddon
Yakov Gluzman
Peter Bohlen
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE204604T1 publication Critical patent/ATE204604T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • C07K14/503Fibroblast growth factor [FGF] basic FGF [bFGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT94114212T 1993-09-24 1994-09-09 Strukturanaloge von fibroblasten- wachstumsfaktoren, die eine modifizierte heparin- bindungsstelle aufweisen ATE204604T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12697493A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
ATE204604T1 true ATE204604T1 (de) 2001-09-15

Family

ID=22427669

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94114212T ATE204604T1 (de) 1993-09-24 1994-09-09 Strukturanaloge von fibroblasten- wachstumsfaktoren, die eine modifizierte heparin- bindungsstelle aufweisen

Country Status (13)

Country Link
EP (1) EP0645451B1 (enExample)
JP (1) JPH07149797A (enExample)
KR (1) KR100320803B1 (enExample)
AT (1) ATE204604T1 (enExample)
AU (1) AU680533B2 (enExample)
CA (1) CA2132668A1 (enExample)
DE (1) DE69428013T2 (enExample)
DK (1) DK0645451T3 (enExample)
ES (1) ES2161233T3 (enExample)
NZ (1) NZ264529A (enExample)
PT (1) PT645451E (enExample)
TW (1) TW275068B (enExample)
ZA (1) ZA947454B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
AU3170499A (en) * 1998-04-28 1999-11-16 Eisai Co. Ltd. Fibroblast growth factor mutein compositions and methods of use therefor
JP5767314B2 (ja) 2010-04-16 2015-08-19 ソーク インスティチュート フォー バイオロジカル スタディーズ Fgfを用いて代謝障害を処置するための方法
US9475856B2 (en) 2012-03-02 2016-10-25 New York University Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders
US9657075B2 (en) 2012-06-07 2017-05-23 New York University Chimeric fibroblast growth factor 23 proteins and methods of use
US9474785B2 (en) 2012-06-07 2016-10-25 New York University Chimeric fibroblast growth factor 19 proteins and methods of use
US9464126B2 (en) 2012-06-07 2016-10-11 New York University Chimeric fibroblast growth factor 21 proteins and methods of use
US9550820B2 (en) 2013-02-22 2017-01-24 New York University Chimeric fibroblast growth factor 23/fibroblast growth factor 19 proteins and methods of use
WO2015061331A1 (en) 2013-10-21 2015-04-30 Salk Institute For Biological Studies Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
CN105828833A (zh) 2013-10-21 2016-08-03 萨克生物研究学院 突变的成纤维细胞生长因子(fgf)1及使用方法
CA3002400A1 (en) 2015-10-30 2017-05-04 Salk Institute For Biological Studies Treatment of steroid-induced hyperglycemia with fibroblast growth factor (fgf) 1 analogs
KR20170109207A (ko) * 2016-03-17 2017-09-28 중앙대학교 산학협력단 화학반응을 통하여 결합된 섬유아세포 증식인자-헤파린 복합체 및 이의 제조 방법
US11229681B2 (en) * 2017-07-14 2022-01-25 The Regents Of The University Of California Dominant-negative FGF2 antagonists
US11542309B2 (en) 2019-07-31 2023-01-03 Salk Institute For Biological Studies Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
CN116042681A (zh) * 2022-08-01 2023-05-02 普纳思细胞(厦门)生物科技有限公司 一种bFGF热稳定性改造的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2879148B2 (ja) * 1987-07-07 1999-04-05 サイオス インコーポレイテッド 組換え繊維芽細胞成長因子
WO1989004832A1 (en) * 1987-11-24 1989-06-01 Amgen Inc. Analogs of fibroblast growth factor
GB8821795D0 (en) * 1988-09-16 1988-10-19 Erba Carlo Spa New derivatives of human/bovine basic fibroplast growth factor

Also Published As

Publication number Publication date
PT645451E (pt) 2001-12-28
EP0645451A1 (en) 1995-03-29
NZ264529A (en) 1997-06-24
ES2161233T3 (es) 2001-12-01
JPH07149797A (ja) 1995-06-13
ZA947454B (en) 1995-05-15
AU680533B2 (en) 1997-07-31
DE69428013D1 (de) 2001-09-27
CA2132668A1 (en) 1995-03-25
TW275068B (enExample) 1996-05-01
AU7418594A (en) 1995-04-06
DE69428013T2 (de) 2002-05-29
KR100320803B1 (ko) 2002-06-20
DK0645451T3 (da) 2001-10-08
EP0645451B1 (en) 2001-08-22

Similar Documents

Publication Publication Date Title
DE69428013D1 (de) Strukturanaloge von Fibroblasten-Wachstumsfaktoren, die eine modifizierte Heparin-Bindungsstelle aufweisen
DE69019578D1 (de) Baustahl mit hoher Festigkeit und guter Bruchzähigkeit.
ATE108459T1 (de) Antagonisten des fibroblasten-wachstumsfaktors.
DE60207740D1 (de) Muteine von menschlichem mit neutrophiler gelatinase-asoziiertem lipocalin und damit verwandte proteine
KR910003102A (ko) 사람 에리트로포이에틴의 뮤테인
ATE209707T1 (de) Aushärtbare legierung mit einer kombination von hoher festigkeit und guter zähigkeit
NO910591L (no) Lavtaps, analog faseforskyver med nesten 360 grader faseforskyvning i x-baandet.
ATE37413T1 (de) Stahltraeger.
KR900702027A (ko) 사람 / 소의 염기성 섬유 아세포 성장 인자의 유도체
DE69126049D1 (de) Vektoren und Zusammensetzungen zur Expression von Glykosilationsmutanten des menschlichen Proteins-C
DE69718359D1 (de) Verankerungsschaft, insbesondere zur Verwendung in Prothesen
KR930008148A (ko) 변이 인간 프로우로키나아제
DE69001213D1 (de) Brueckensystem zur ueberwindung von graeben durch fahrzeuge.
ATE90566T1 (de) Polysaccharidfraktion mit einer wirkung gegen hiv.
SE8401475D0 (sv) Truss-webb
ATE47402T1 (de) Verfahren zur herstellung von mukopolysaccharidzusammensetzungen welche eine hohe antithrombogene aktivitaet besitzen.
ES2075784A2 (es) Procedimiento para la construccion de tableros de tipo cajon, para puentes, con vigas en u.
ES276692U (es) Silla alta plegable mejorada
ATE25573T1 (de) Anordnung in einem betaetiger zur hoeheneinstellung von arbeitsbuehnen.
ES1003876U (es) Soporte para el corte de lena perfeccionado.
ES1033857U (es) Herramienta niveladora.
ES1014611U (es) Pata perfeccionada para mesas.
ES294300U (es) Union de railes en diagonal
ES1004218U (es) Parque infantil
ES1022808U (es) Entramado metalico perfeccionado.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee